Glenmark Pharmaceuticals Ltd share price logo

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

BSE: 532296

Mid Cap

Pharma Sector

₹2299.50

-35.50

(-1.52%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Glenmark Pharma Stock Performance

as on April 24, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,283.20
    ₹2,372.80
    downward going graph

    0.71%

    Downside

    3.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,336.30
    ₹2,372.80
    downward going graph

    41.89%

    Downside

    3.19%

    Upside

    downward going graph

Glenmark Pharma share price movements today

Previous Close
₹2,335.00
Open
₹2,351.00
Volume
8.38L
Upper Circuit
₹2,568.50
Lower Circuit
₹2,101.50
Day's Low - High
₹2,283.20 - ₹2,372.80
52 Week Low - High
₹1,336.30 - ₹2,372.80

Glenmark Pharma Historical Returns

1 Month Return
+ 5.94 %
3 Month Return
+ 14.99 %
1 Year Return
+ 63.36 %
3 Year Return
+ 341.15 %
5 Year Return
+ 316.46 %

Glenmark Pharma Fundamentals

as on April 24, 2026 at 4:01 pm IST

Market Cap

₹64,892.08 Cr

Return on Equity (ROE)

6.78

PE Ratio (TTM)

60.93

Return on capital employed (ROCE)

8.94

Industry PE ratio

42.79

Beta (LTM)

0.6

P/B Ratio

1.77

Dividend Yield

0.16

PEG Ratio

1.39

Quarterly Earnings Growth YOY

15.86

EPS (TTM)

37.11

Sector

Pharmaceuticals

Book Value

313.6

Technical Analysis

Bullish

Glenmark Pharma Stock Valuation

as on April 24, 2026 at 4:01 pm IST

Glenmark Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-275.05x)

December 28, 2023

Industry (42.79x)

April 24, 2026

Today (60.93x)

April 24, 2026

Highest (95.94x)

September 14, 2023

LowHigh

Today’s Price to Earnings Ratio: 60.93x

Glenmark Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Glenmark Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY64,892.0863.29%0.621,04713,321
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY13,776.24-6.81%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,060.223.46%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY4,519.94-3.71%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY12,616.6935.19%0.672441,515
See all

Market expectation of Glenmark Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

77.78%

Buy

11.11%

Hold

11.11%

Sell

Glenmark Pharma Stock’s Investor Sentiment and Interest

Investment in Glenmark Pharmaceuticals Ltd Shares on INDmoney has dropped by -26.12% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-26.12% versus previous 30 day period

Search interest for Glenmark Pharmaceuticals Ltd Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Glenmark Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
2,998.47
3,160.69
2,460.29
3,016.01
3,223.3
3,400.5
3,301.9
3,220.13
3,059.33
6,003.79
3,888
Other Income
19.72
120.43
164.18
797.54
31.49
39.42
31.13
11.69
26.44
200.63
44.47
Total Income
3,055.79
3,327.81
2,670.88
3,860.49
3,275.68
3,473.21
3,418.68
3,267.89
3,290.88
6,247.5
3,945.08
Expenses
2,650.74
3,070.52
2,792.07
3,005.39
2,655.97
2,831.88
2,787.32
3,068
3,007.15
5,072.44
3,215.2
Operating Profit
347.73
90.17
-331.78
10.62
567.33
568.62
514.58
152.13
52.18
931.35
672.8
Operating Profit Margin %
11.6%
2.85%
-13.49%
0.35%
17.6%
16.72%
15.58%
4.72%
1.71%
15.51%
17.3%
Profit Before Interest, Tax and Depreciation
405.05
257.3
-121.2
855.1
619.71
641.33
631.36
199.89
283.73
1,175.06
729.88
Interest
111.61
121.46
134.34
148.56
39.58
48.48
52.29
66.71
58.23
66.46
41.43
Depreciation
142.04
141.45
147.08
151.34
117.79
120.28
122.74
125.21
129.93
141.2
154.45
Profit Before Tax
151.4
-5.61
-402.62
555.2
462.34
472.57
456.33
7.97
95.57
967.4
534
Tax Paid
-21.73
55.95
-71.8
1,769.47
122.09
118.09
108.29
3.59
48.6
356.97
130.77
Profit After Tax
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
403.23
Total Net profit including share of profit / Loss from associate company
173.13
-61.56
-330.82
-1,214.27
340.24
354.49
348.03
4.38
46.97
610.43
403.23
EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
Actual EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
Adjusted EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.63
14.29
Diluted EPS
5.31
-2.9
-12.45
-43.17
12.06
12.55
12.33
0.16
1.66
21.62
14.28

Glenmark Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
8,972.23
9,705.08
10,397.23
10,806.03
12,174.2
11,431.94
11,635.46
13,145.84
Other Income
91.4
375.32
192.48
94.76
166.67
755.86
1,237.32
113.72
Total Income
9,194.47
10,240.79
10,833.45
11,038.69
12,471.58
12,339.1
13,050.42
13,435.46
Expenses
7,487.7
8,279.67
8,942.89
8,859.55
10,245.52
10,714.08
11,518.72
11,343.18
Operating Profit
1,484.53
1,425.41
1,454.34
1,946.48
1,928.68
717.86
116.74
1,802.66
Operating Profit Margin %
16.55%
14.69%
13.99%
18.01%
15.84%
6.28%
1%
13.71%
Profit Before Interest, Tax and Depreciation
1,706.77
1,961.12
1,890.56
2,179.14
2,226.06
1,625.01
1,531.7
2,092.28
Interest
285.57
334.59
377.32
353.11
298.1
349.04
515.97
207.07
Depreciation
301.88
325.91
417.17
443.55
486.72
569.17
581.91
486.01
Profit Before Tax
1,119.32
1,300.62
1,096.07
1,382.48
1,441.24
706.8
433.82
1,399.2
Tax Paid
315.46
375.63
320.11
412.39
447.6
329.4
1,867.34
352.07
Profit After Tax
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
Total Net profit including share of profit / Loss from associate company
803.87
924.99
775.97
970.09
993.65
377.4
-1,433.52
1,047.14
EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Actual EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Adjusted EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.11
Diluted EPS
28.49
32.78
27.5
34.38
33.37
10.53
-53.22
37.1

Glenmark Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
344.85
657.43
1,648.05
1,324.17
1,392.41
1,131.21
1,108.65
625.39
-265.44
-827.6
Cash Flow from Investing Activities
-950.06
-1,001.34
-1,002.56
-882.52
-773.75
-661.62
-315.74
-515.43
4,386.81
58
Cash Flow from Financing Activities
698.6
543.14
-468.49
-738.74
-444.65
-441.78
-463.11
75.27
-3,906.13
787.04
Net Cash Flow
93.39
199.24
176.99
-297.08
174
27.82
272.43
32.5
215.24
17.44

Glenmark Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
46.65%
46.65%
46.65%
46.64%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
46.65%
DII
9.11%
10.32%
10.92%
13.36%
13.92%
13.21%
13.85%
14.6%
17.64%
18.61%
20.09%
19.29%
FII
0%
24.8%
23.71%
21.38%
20.98%
23.05%
23.51%
23.16%
20.62%
20.73%
19.2%
20.34%
Government
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
0.04%
Public
18.68%
18.2%
18.69%
18.58%
18.41%
17.06%
15.96%
15.56%
15.06%
13.97%
14.02%
13.68%
Total Outstanding Shares
28,21,68,156
28,21,68,156
28,21,68,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,21,88,156
28,22,00,809
28,22,00,809
28,22,00,809
28,22,00,809
Total Shareholders
2,36,908
2,32,685
2,09,931
1,99,451
1,92,630
1,93,949
1,95,059
1,92,724
1,90,210
1,98,789
2,01,584
1,96,105

Mutual Funds that own Glenmark Pharma Stock

Check out the Mutual Funds with significant holdings in Glenmark Pharma .

Glenmark Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Glenmark Pharma .

  • Glenmark Pharmaceuticals Ltd Earnings Results

    Glenmark Pharmaceuticals Ltd’s net profit jumped 15.88% since last year same period to ₹403.21Cr in the Q3 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -33.94% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Glenmark Pharmaceuticals Ltd Dividends September,2025

    In the quarter ending June 2025, Glenmark Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 26 Sep 2025 - translating a dividend yield of 0.22%.

    Read More about Dividends

Indices Featuring Glenmark Pharma Stock

Check stock indices that include Glenmark Pharma .

NIFTY PHARMA

₹22,580.10

-1.77 (▲406.25%)

Nifty LargeMidcap 250

₹16,113.40

-1.04 (▲169.05%)

S&P BSE 150 MidCap

₹16,036.82

-1.00 (▲162.05%)

Nifty Alpha 50

₹50,876.65

-0.43 (▲220.50%)

Nifty Midcap 100

₹59,374.80

-0.96 (▲578.00%)

Nifty Healthcare

₹14,570.60

-1.49 (▲220.05%)

Nifty 500

₹22,570.05

-1.06 (▲240.80%)

Nifty Midcap 150

₹21,875.95

-1.01 (▲223.35%)

Nifty MidSmallcap 400

₹19,862.00

-1.03 (▲206.95%)

S&P BSE Momentum

₹2,144.63

-0.52 (▲11.28%)

BSE Healthcare

₹43,616.92

-1.35 (▲597.52%)

Nifty 200

₹13,656.85

-1.05 (▲144.50%)

S&P BSE 250 LargeMidCap

₹10,522.69

-1.05 (▲111.99%)

BSE 500

₹35,349.66

-1.06 (▲380.05%)

S&P BSE 400 MidSmallCap

₹11,867.91

-1.05 (▲126.35%)

Insights on Glenmark Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, GLENMARK has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, GLENMARK stock has moved up by 26.9%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 19.20% to 20.35% in Mar 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.65% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 17.86% to 16.80% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 14.02% to 13.68% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 6.24K Cr → 3.94K Cr (in ₹), with an average decrease of 36.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 610.35 Cr → 403.21 Cr (in ₹), with an average decrease of 33.9% per quarter

Glenmark Pharma Stock Futures & Options Contracts

View the latest movement in Glenmark Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Glenmark Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 28 Apr ₹2400 Call
April 28, 2026
₹2400
₹4.05
-12.3
-75.23%
GLENMARK 28 Apr ₹2360 Call
April 28, 2026
₹2360
₹8.8
-18.8
-68.12%
GLENMARK 28 Apr ₹2380 Call
April 28, 2026
₹2380
₹6
-15.55
-72.16%
GLENMARK 28 Apr ₹2340 Call
April 28, 2026
₹2340
₹12.95
-21.7
-62.63%

Glenmark Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
GLENMARK 26 May Fut
May 26, 2026
-
₹2294.7
-53.78
-2.29%
GLENMARK 28 Apr Fut
April 28, 2026
-
₹2281.9
-54.68
-2.34%
GLENMARK 30 Jun Fut
June 30, 2026
-
₹2320
-44.94
-1.9%

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is an Indian pharmaceuticals company listed on the National Stock Exchange and Bombay Stock Exchange. Established in 1977, the company manufactures and distributes branded and generic formulations, active pharmaceutical ingredients (API’s) and biosimilars. It has 18 manufacturing facilities in India, 7 in the U.S., 1 in Brazil and 1 in Mexico that span across the world catering to global requirements. Glenmark has taken several steps towards achieving a healthy presence in the global markets. In addition to its product portfolio, Glenmark’s aggressive acquisition strategy and product launch activities have helped expand its market reach. The company has been awarded numerous accolades over the years, including consecutive years of being ranked amongst the top 1000 world pharmaceutical companies. It continues to be a frontrunner in providing quality and affordable healthcare solutions in India and abroad.

Revenue: ₹3,888.00Cr as on December 2025 (Q3 FY26)
Net Profit: ₹403.23Cr as on December 2025 (Q3 FY26)
Listing date: 07 Feb, 2000
Chairperson Name: Glenn Saldanha
OrganisationGlenmark Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOGlenn Saldanha
E-voting on sharesClick here to vote

FAQs

What is Glenmark Pharma share price today?

Glenmark Pharma share price today stands at ₹2299.5 as on at the close of the market. Glenmark Pharma share today touched a day high of ₹2372.8 and a low of ₹2283.2.

What is the 52 week high and 52 week low range for Glenmark Pharma share?

Glenmark Pharma touched a 52 week high of ₹2372.8 and a 52 week low of ₹1336.3. Glenmark Pharma share price today i.e. is closed at ₹2299.5, which is -3.09% down from its 52 week high and 72.08% up from its 52 week low.

What is Glenmark Pharma 's market capitalisation today?

Glenmark Pharma market capitalisation is ₹64,892.08 Cr as on .

How to buy Glenmark Pharma shares?

To buy Glenmark Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for GLENMARK or Glenmark Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Glenmark Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Glenmark Pharma trading volume today?

Glenmark Pharma trading volume is 8.38L as on . This means that 8.38L shares of Glenmark Pharma were bought and sold on the stock market during today's trading session.